← FDA Drug Approvals (Drugs@FDA)

PIPERACILLIN AND TAZOBACTAM

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: APOTEX · Approved 2017-03-17

Drug application

FDA Application #

ANDA207146

Application type

Abbreviated New Drug Application (Generic)

Brand name

PIPERACILLIN AND TAZOBACTAM

Generic name

Piperacillin Sodium

Active ingredients

PIPERACILLIN SODIUM; TAZOBACTAM SODIUM

Dosage form

INJECTABLE

Route

INJECTION

Marketing status

Prescription

Sponsor

APOTEX

First approval

2017-03-17

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown